Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program
Sign Up to like & getrecommendations! Published in 2019 at "Diabetologia"
DOI: 10.1007/s00125-019-4839-8
Abstract: Aims/hypothesisThe primary analysis of the Canagliflozin cardioVascular Assessment Study (CANVAS) Program showed canagliflozin to have a beneficial effect on cardiovascular and renal outcomes in people with type 2 diabetes at high cardiovascular risk, but also… read more here.
Keywords: canvas program; amputation; risk; canagliflozin ... See more keywords
Predictive factors and nomogram to evaluate the risk of below-ankle re-amputation in patients with diabetic foot
Sign Up to like & getrecommendations! Published in 2022 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2022.2125257
Abstract: Abstract Background Diabetes mellitus, as the most common metabolic disease, is common worldwide and represents a crucial global health concern. The purpose of this research was to investigate the related risk factors and to develop… read more here.
Keywords: diabetic foot; amputation nomogram; risk; analysis ... See more keywords
Elabela as a novel marker: Well-correlated with WIfI amputation risk score in lower extremity arterial disease patients.
Sign Up to like & getrecommendations! Published in 2021 at "Anatolian journal of cardiology"
DOI: 10.14744/anatoljcardiol.2020.17329
Abstract: OBJECTIVE Worldwide, over 200 million people are diagnosed with lower extremity arterial disease (LEAD). LEAD significantly increases the risk of death and amputation of the lower limb. A new classification system (WIfI) has been proposed… read more here.
Keywords: amputation; risk; wifi amputation; extremity arterial ... See more keywords